®

Tenomin 50
®

Tenomin 50
Atenolol BP 50 mg tablet

Tenomin® 50
Contraindications
Atenolol is contraindicated with a known hypersensitivity to atenolol,

Atenolol BP 50 mg
severe bradycardia, second or third degree heart block,
uncontrolled heart failure, hypotension, severe peripheral vascular
disease (including intermittent claudication), sick sinus syndrome,
Atenolol BP 50 mg tablet
Composition cardiogenic shock, phaeocromocytoma (without a concomitant
Tenomin® 50 Tablet : Each film coated scored tablet contains
alpha blocker), metabolic acidosis.
Atenolol BP 50 mg.

Mode Of Action Drug Interactions

Atenolol (Tenomin®) is a phenylacetamide, a selective β1-blocker. it
blocks the effects of adrenergic stimulation mediated through these
receptors. The cardio-selectivity is dose-related. Atenolol
(Tenomin®) causes a reduction in blood pressure by lowering
cardiac output, decreasing the plasma renin activity & sympathetic
outflow from CNS. Atenolol also causes a reduction in myocardial
oxygen demand by virtue of its negative inotropic and negative
chronotropic effects.
Indications
Hypertension, Angina, Arrhythmias.
Dosage and Administration
Hypertension, 25-50 mg daily (higher doses rarely necessary)
Angina, 100 mg daily in 1 or 2 doses
Arrhythmias, 50 – 100 mg daily
Side-effects
Despite its relative selectivity, atenolol can cause bronchospasms in
asthma patients. Rarely observed side-effects are sleep
disturbances,drymouth, visual disturbances, dry eyes, headache,
thrombocytopenia, reversible mental depression, fatigue,
paresthesia, exanthemas, psoriasis exacerbations and
arthropathies.
The effects of other myocardial depressants including
anti-arrhythmics such as quinidine, procainamide, or lignocaine,
phenytoin, and medicines which interfere with calcium transport,
such as verapamil, may be enhanced by atenolol. The effects of
atenolol are diminished by beta-adrenoceptor stimulating agents
such as isoprenaline; the hypotensive effects of atenolol may be
dangerously reversed and the peripheral vasoconstrictor effects
enhaced by alpha-adrenoceptor stimulating agents such as
noradrenaline or those with mixed alpha-and beta-adrenoceptor
stimulating properties such as adrenaline; bradycardia may also
occur. The effects of atenolol may be enhanced by adrenergic
neuron blocking agents such as guanethidine or bethanidine, or
catecholamine-depleting agents such as reserpine and the
hypotensive effects by diuretics. Atenolol may enhance some of the
cardiac effects of digitalis and diminish others. It has been
suggested that clonidine withdrawal symptoms may be exacerbated
in patients who are concurrently taking a beta blocker.
STORAGE CONDITION:
Keep in cool and dry place, away from light and out of the reach of
children.

Use in Pregnancy and Lactation HOW SUPPLIED

Atenolol can cause fetal harm when administered to a pregnant Box contains 10x10’s tablets in blister strips.
woman. Atenolol crosses the placental barrier and appears in cord
blood. If this drug is used during pregnancy, or if the patient
becomes pregnant while taking this drug, the patient should be
apprised of the potentially hazard to the fetus. Caution should be PACIFIC
exercised when Atenolol is administered to a woman, who is breast PHARMACEUTICALS LTD
Narayangonj, Bangladesh
feeding.

PPL/PMD/AKG/PKS/FHM/Feb’ 2021
This is circulated with the prior approval
. 2015
2015
of Licensing Authority (Drug Administration)

8 x 10.3 inch
300 gsm art card (nimbo)
4 color print
glossy lamination

500 pcs